ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,455.09
0.56%
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs Yen
153.0075
-0.03%
Brent Oil
83.57
-0.07%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Citius Pharmaceuticals Inc (CTXR)

  7. Citius Pharmaceuticals Inc (CTXR) ニュース

CTXR Citius Pharmaceuticals Inc

0.707
0.00 (0.00%)
プレマーケット
最終更新日： 17:00:00
15分遅延
名称 銘柄コード 市場 種別
Citius Pharmaceuticals Inc CTXR NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 0.707 17:00:00
始値 安値 高値 終値 前日終値
0.707
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0105:05PRNUSCitius Pharmaceuticals Announces Closing of $15 Million..
2024/4/2621:00PRNUSCitius Pharmaceuticals Announces $15 Million Registered..
2024/4/1121:30PRNUSCitius Pharmaceuticals Announces Addition of City of Hope to..
2024/4/0421:30PRNUSCitius Pharmaceuticals to Present at the LD Micro..
2024/3/1821:30PRNUSCitius Pharmaceuticals Announces FDA Acceptance of the BLA..
2024/3/0722:30PRNUSCitius Pharmaceuticals, Inc. Secures $2.4 million through..
2024/3/0414:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/2621:30PRNUSCitius Pharmaceuticals Announces Filing of Form S-3 Shelf..
2024/2/2406:23EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/2/2406:18EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2322:30PRNUSCitius Pharmaceuticals to Participate in Upcoming BIO CEO..
2024/2/1522:45EDGAR2Form 8-K - Current report
2024/2/1506:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/1506:30PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal First Quarter..
2024/2/1423:18EDGAR2Form 8-K - Current report
2024/2/1422:01PRNUSCitius Pharmaceuticals Resubmits the Biologics License..
2024/1/2706:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/2706:05EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/2406:05EDGAR2Form 8-K - Current report
2024/1/2322:30PRNUSCitius Pharmaceuticals Announces Nomination of..
2024/1/0606:05EDGAR2Form 8-K - Current report
2024/1/0306:04EDGAR2Form 8-K - Current report
2024/1/0222:31PRNUSCitius Pharmaceuticals Completes Enrollment in Pivotal Phase..
2024/1/0222:30PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023..
2023/12/3006:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/11/0922:30PRNUSCitius Pharmaceuticals to Participate in the Sidoti..
2023/10/3121:45PRNUSCitius Pharmaceuticals Announces Publication in Frontiers of..
2023/10/2420:58EDGAR2Form 425 - Prospectuses and communications, business..
2023/10/2420:53EDGAR2Form 8-K - Current report
2023/10/2420:30PRNUSCitius Pharmaceuticals Executes Definitive Agreement to..
2023/10/1305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2605:30EDGAR2Form 8-K - Current report
2023/9/2122:35GLOBEDawson James Securities Announces October Date for 8th..
2023/9/1905:30PRNUSCitius Pharmaceuticals Reschedules Participation in Sidoti..
2023/9/1605:30EDGAR2Form 8-K - Current report
2023/9/1405:30PRNUSCitius Pharmaceuticals Mourns the Loss of Board Member,..
2023/9/1122:53EDGAR2Form 8-K - Current report
2023/9/0821:40EDGAR2Form 8-K - Current report
2023/9/0821:00PRNUSCitius Pharmaceuticals, Inc. Receives Regulatory Guidance..
2023/9/0705:30PRNUSCitius Pharmaceuticals to Participate in H.C. Wainwright and..
2023/8/1522:25EDGAR2Form 8-K - Current report
2023/8/1505:15PRNUSCitius Pharmaceuticals, Inc. Reports Fiscal Third Quarter..
2023/8/1505:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1105:15EDGAR2Form 8-K - Current report
2023/8/1021:37PRNUSCitius Pharmaceuticals Reaches 92 Event Milestone in..
2023/8/0105:15EDGAR2Form 8-K - Current report
2023/7/3005:16PRNUSCitius Pharmaceuticals, Inc. Receives a Complete Response..

最近閲覧した銘柄

NASDAQ
CTXR
Citius Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有